Related by context. All words. (Click for frequent words.) 83 evaluating tivozanib 80 5 FU leucovorin 78 trastuzumab Herceptin R 78 refractory chronic lymphocytic 78 irinotecan doxorubicin oxaliplatin paclitaxel 77 sorafenib Nexavar ® 77 metaglidasen 76 CYT# potent vascular disrupting 76 erlotinib Tarceva ® 76 Vidaza ® 76 Xeloda ® 76 XL# anticancer compounds 76 docetaxel Taxotere R 76 TO AVOID PREGNANCY WHILE 76 evaluating satraplatin 75 sorafenib tablets 75 sorafenib Nexavar R 75 bevacizumab Avastin R 75 R sorafenib tablets 75 HGS ETR1 mapatumumab 75 bortezomib Velcade R 75 HGS# 75 TRIOLEX HE# APOPTONE HE# 75 undergoing elective percutaneous 74 prednisone CHOP 74 virus HCV protease inhibitor 74 evaluating picoplatin 74 recurrent metastatic ovarian cancer 74 FUSILEV enhances 74 Fludara ® 74 Completes Patient Enrollment 74 chemotherapy FOLFOX 74 5 fluorouracil leucovorin 74 Initiates Enrollment 74 capecitabine Xeloda 74 IMiDs ® 74 orally administered inhibitor 74 dextromethorphan quinidine 74 oral levofloxacin 74 metformin sulfonylurea 74 alfa 2a 73 ATRA IV 73 sulfonylurea glimepiride 73 Gemzar ® 73 ® lenalidomide 73 plus Copegus R 73 FOLFOX6 73 novel VDA molecule 73 cisplatin gemcitabine 73 R lenalidomide 73 lintuzumab SGN 73 lenalidomide Revlimid R 73 AAG geldanamycin analog 73 R Saizen R 73 Skinvisible receives 73 Albuferon TM 73 candidates Azedra TM 73 pertuzumab 73 MAGE A3 ASCI 73 developing Bicifadine serotonin 73 LymphoStat B belimumab 73 evaluating T DM1 73 sorafenib Nexavar 73 Pegasys ® 73 Panzem R NCD 73 bevacizumab Avastin ® 72 vapreotide acetate 72 FEMALES SHOULD BE ADVISED 72 Crofelemer budesonide foam 72 CYP#A# CYP#D# 72 coronary stent merged 72 oral picoplatin 72 brand ciclesonide HFA 72 Phase 1b trial 72 lenalidomide Revlimid ® 72 oral prodrug 72 Meets Primary Endpoint 72 INSPIRE Trial Phase III 72 Panzem R 72 Hsp# Inhibitor 72 PNP inhibitor 72 ® bortezomib 72 SPRYCEL ® 72 Mg Usa 72 plus prednisone prednisolone 72 Deforolimus 72 interferon gamma 1b 72 cetuximab Erbitux R 72 pralatrexate injection folate analogue 72 vinca alkaloid 72 cyclophosphamide doxorubicin vincristine 72 infliximab monotherapy 72 docetaxel Taxotere ® 72 Zenvia ™ 72 Combination REOLYSIN R 72 Vytorin combines 72 DNA methyltransferase inhibitors 72 2 methoxyestradiol 72 COPEGUS R 72 tenofovir emtricitabine 72 pan histone deacetylase 72 metastatic colorectal carcinoma 72 erlotinib Tarceva R 72 Bayer HealthCare Onyx Pharmaceuticals 72 HMG CoA reductase inhibitors 72 commercializes implantable 72 ocular formulation 72 TTF Therapy 72 Phase #b/#a clinical 72 primary hypercholesterolemia 71 Aflibercept 71 Pegasys R 71 Exelixis compounds 71 Elotuzumab 71 LymphoStat B TM 71 HGS ETR2 71 metastatic pancreatic 71 pegylated interferon alfa 2a 71 paclitaxel Taxol ® 71 Investigational Oral 71 Initiates Phase II 71 humanized therapeutic 71 metastatic castration resistant 71 IMPDH inhibitor 71 TRANSDUR ® 71 inflammatory PDE 71 plus Copegus 71 oral chemotherapeutic agent 71 Platinol ® cisplatin 71 gemcitabine chemotherapy 71 demonstrated antitumor activity 71 TNF Tumor Necrosis Factor 71 dasatinib Sprycel 71 pharmacogenomic translational research 71 HCV NS5B polymerase 71 dasatinib Sprycel ® 71 hypoxia activated prodrug 71 thalidomide Thalomid 71 Vidaza R 71 Budesonide foam crofelemer 71 temsirolimus Torisel ® 71 dimebon latrepirdine 71 oral deforolimus 71 infusional 5-FU/LV 71 mapatumumab 71 evaluating Actimmune 71 alvespimycin 71 VEGFR2 inhibitor 71 IMiDs R 71 Glufosfamide 71 temsirolimus Torisel 71 PEGINTRON TM 71 Imprime PGG 71 kidney urologic 71 Phase 2b Clinical Trial 71 evaluating adecatumumab 71 Panzem NCD 71 Omacetaxine 71 Xelox 71 Launches Generic Version 71 Pruvel TM 71 Romidepsin 71 sarcoma melanoma 71 Oral Fingolimod 71 Dementia Related Psychosis 71 metformin sulfonylureas 71 Telik logo TELINTRA 71 Patients Treated With 71 sunitinib Sutent ® 71 CTAP# Capsules 71 oral nucleoside analogue 70 Imprime PGG ® 70 S1P antibody 70 interferon beta 1a infertility 70 Phase 1b clinical trials 70 JAK2 Inhibitor 70 Hormone Refractory Prostate Cancer 70 Empatic ™ 70 NS5B polymerase 70 galiximab 70 gemcitabine Gemzar 70 ThermoDox R 70 % pramoxine HCl 70 IMiDs ® compound 70 Presents Preclinical Data 70 elotuzumab 70 generation Hsp# inhibitor 70 Xcytrin R 70 novel emulsion formulation 70 radiation chemoradiation 70 nilotinib Tasigna ® 70 Treatment Naïve 70 plus prednisone 70 ribavirin RBV 70 non nucleoside inhibitor 70 Mg Uk 70 By JENNIFER LEARN 70 Tezampanel 70 CHEAP ONLINE PHARMACY LOW 70 known dihydropyrimidine dehydrogenase 70 ritonavir boosted 70 Peginterferon alfa 2b 70 valsartan amlodipine 70 metastatic ocular 70 dihydrochloride Tablets 70 ELOXATIN 70 PRN FDA Approves 70 lexidronam injection 70 mocetinostat MGCD# 70 Zorbtive TM 70 Randomized Double blind 70 Initiates Clinical Trial 70 Amigal TM 70 Presents Preclinical 70 Rigel R# 70 BCG refractory carcinoma 70 dependent kinase inhibitor 70 Relapsed Refractory 70 induced mucositis 70 bone marrow reticulin deposition 70 novel orally inhaled 70 AVASTIN 70 TELINTRA 70 Folfox 70 systemic anaplastic large 70 Entereg R 70 relapsed MM 70 MEK Inhibitor 70 Copegus R 70 essential thrombocythemia ET 70 ThermoDox ® clinical 70 Oral NKTR 70 Peginterferon alfa 2a 70 Novacort TM 70 Aeolus Pharmaceuticals Announces 70 bortezomib Velcade 70 MGd 70 FDA APPROVES 70 Demonstrates Positive 70 induced macular edema 70 Primary Hypercholesterolemia 70 neratinib 70 Serostim ® 70 Copegus ® 70 hydroxymethyl coenzyme 70 CD# CEA 70 oxaliplatin Eloxatin 70 solid tumors ZYBRESTAT 70 PI3K/Akt pathway inhibitor 70 hormone refractory metastatic prostate 70 compound INCB# 70 forodesine 70 Epothilone D 70 q8h 69 docetaxel chemotherapy 69 liposomal doxorubicin 69 Amgen Neulasta R 69 methylnaltrexone bromide 69 generation purine nucleoside 69 triggers apoptosis programmed 69 ACTEMRA TM 69 recombinant PSMA vaccine 69 pegylated interferon peg IFN 69 ALN HPN 69 ribavirin USP 69 evaluating mipomersen 69 TELINTRA R 69 evaluating intravenous picoplatin 69 adenosine injection 69 albiglutide 69 liposomal formulation 69 Initiates Phase III 69 Complicated Skin 69 GVAX ® 69 gemcitabine Gemzar ® 69 chemotherapy fludarabine 69 tumor activated prodrug 69 pharmacologically active isomer 69 acetonide FA 69 Ovitrelle R Serostim 69 Zolpimist ™ 69 Interferon beta 1a 69 intra arterial chemotherapy 69 EXPLORE Xa 69 miconazole Lauriad ® 69 oral ridaforolimus 69 Pruvel ™ prulifloxacin 69 humanised monoclonal antibody 69 FOLOTYN ® 69 AEGR 69 monoclonal antibody IgG1 Mab 69 markets COLAZAL 69 lenalidomide dexamethasone 69 Novel Oral 69 intravesical infusion therapy 69 Study Evaluating 69 orally inhaled migraine 69 CCX# B 69 Cetuximab Erbitux 69 METOZOLV ™ ODT metoclopramide 69 dacarbazine DTIC 69 novel synthetic PEGylated 69 Tarceva TM 69 gemcitabine carboplatin 69 progressive metastatic prostate 69 myocardial infarction ventricular fibrillation 69 Aflibercept VEGF Trap 69 receptor tyrosine kinase inhibitor 69 Antitumor Activity 69 Xeloda capecitabine 69 visilizumab 69 weekly subcutaneous injections 69 THAT ARE DIFFICULT TO 69 dexamethasone Decadron 69 certain protein tyrosine 69 opioid naive 69 XL# XL# XL# XL# 69 metastatic androgen independent 69 ongoing Phase 1b 69 ceftazidime 69 carboplatin paclitaxel 69 hypoxia selective 69 Camptosar ® 69 rash pruritus nausea 69 myelodysplastic myeloproliferative diseases 69 metastatic hormone refractory 69 idarubicin 69 AN# topical anti 69 gastrointestinal stromal 69 SCH # 69 Sapacitabine 69 Naive Patients 69 hyperphenylalaninemia HPA due 69 Atripla combines 69 Begins Dosing 69 SIX RO ROG 69 CINQUIL 69 memantine HCl 69 agents Tabun Sarin 69 BRAF inhibitor 69 headache nasopharyngitis 69 deCODE AF TM 69 Previously Untreated 69 Receives Orphan Drug Designation 69 Personalized Immunotherapy 69 pegylated liposomal doxorubicin 69 Vildagliptin 69 combines bupropion 69 Solazed TM 69 aplastic anemia AA 69 pentadentate logo R 69 oncolytic virus therapies 69 telaprevir dosed 69 INCB# [001] 69 teriflunomide 69 prokinetic agent 69 sapacitabine CYC# 69 acyclovir Lauriad R 69 HGS ETR1 69 Refractory Hodgkin Lymphoma 69 oral rivaroxaban 69 Phase Ib clinical trials 69 Neulasta R 69 unique alkylating agent 69 successfully commercialize Iluvien 69 catheter occlusion 69 Phase IIb Trial 69 Contrave# 69 Humanized Anti 69 COPEGUS ribavirin 69 sodium glucose cotransporter 68 OSI Tarceva 68 ACAPODENE TM 68 5 Fluorouracil 68 Pegasys peginterferon alfa 2a 68 Initiate Phase 68 registrational Phase 68 pegylated interferons 68 selective A2A adenosine receptor 68 PROVENGE ® 68 FUSILEV ® 68 FOLFIRI 68 TLK# 68 Oracea TM 68 evaluating carfilzomib 68 peptidic compound 68 Emtriva Viread 68 azilsartan medoxomil 68 topical gel formulation 68 clinical trials Archexin 68 cetuximab Erbitux ® 68 forodesine purine nucleoside phosphorylase 68 plus dacarbazine 68 R roscovitine CDK cyclin 68 multicenter Phase III 68 pregabalin Lyrica 68 ergot derivatives 68 naloxol derivative 68 maximally tolerated dose 68 retinal vein occlusion induced 68 MEDAREX 68 DG# compounds targeting 68 personalized cellular immunotherapy 68 allosteric modulator PAM 68 doxorubicin cyclophosphamide 68 novel antimitotic agent 68 commercialize CorMedix drug 68 candidate AQ4N 68 Leukine ® 68 zonisamide SR 68 pioglitazone HCl 68 OMNARIS HFA 68 Previously Treated 68 Perforomist ™ Inhalation Solution 68 Completes Enrollment 68 Medoxomil 68 d l leucovorin 68 including cyclosporine methotrexate 68 Xanafide 68 paroxetine sertraline 68 aspirin clopidogrel 68 Dyloject TM 68 Vaccine Adjuvant 68 formerly LymphoStat B 68 bendamustine ifosfamide 68 topical antifungal steroid 68 thetreatment 68 mitoxantrone plus 68 plus gemcitabine 68 Veronate R 68 melphalan prednisone 68 worsening thrombocytopenia 68 Randomized Phase 68 Racivir 68 IAP inhibitor 68 Peg IFN 68 Peginterferon 68 prednisone prednisolone plus 68 selective estrogen receptor modulator 68 advanced hepatocellular carcinoma 68 sunitinib malate 68 generation DACH Platinum 68 ENMD # 68 potentially hepatotoxic 68 delta gamma agonist 68 Annamycin 68 Novolimus 68 alpha 2b 68 Serdaxin ® 68 blinded randomized placebo controlled 68 Pemetrexed 68 chemotherapeutic agents carboplatin 68 Zoraxel TM 68 Targretin 68 elderly myelodysplastic syndromes 68 standard chemotherapy regimen 68 castration resistant hormone refractory 68 receiving VELCADE 68 IMiDs 68 advanced metastatic renal 68 Cutaneous T 68 Demonstrates Significant 68 SILENOR 68 DEB# 68 receiving INTRON 68 PRICE GREAT DISCOUNT FREE 68 Pharma Merck Serono 68 naïve HCV 68 SCHIZOPHRENIA DISORDERS SUPPORT GROUP 68 Phase 2b Trial 68 PEGASYS ® 68 Nexavar ® 68 FOLFIRI chemotherapy 68 ENL recurrence 68 benazepril 68 DexaSite 68 Pruvel ™ 68 including eniluracil ADH 68 ZOLINZA 68 HuCAL PLATINUM ® CysDisplay 68 pan HDAC inhibitor 68 EDEMA3 trial 68 Abstract Accepted 68 paclitaxel poliglumex 68 IL# PE#QQR 68 modified glutathione analog 68 Brentuximab Vedotin SGN 68 CDK cyclin dependent 68 TM Aganocide 68 cyclophosphamide methotrexate 68 indinavir Crixivan 68 volociximab 68 gefitinib Iressa 68 Luveris R Ovidrel R 68 accumulate preferentially 68 Announces Tentative Approval 68 selective orally bioavailable 68 Fovea Pharmaceuticals subsidiary 68 hypertrichosis occurred 68 CCR9 antagonist 68 Ribavirin causes 68 interferon alfa 2a 68 cisplatin carboplatin 68 Pivotal Phase 68 beta 1a 68 Dapagliflozin 68 Shows Promise Against 68 plus dexamethasone 68 PROCTOCORT R Suppository Hydrocortisone 68 Seliciclib 68 R# #mg BID 68 topical antifungal product 68 didanosine associated 68 ADP receptor antagonist 68 pegylated interferon alpha 2a 68 novel topoisomerase 68 PDX pralatrexate 68 risperidone Risperdal 68 Takeda Kyowa Hakko Kirin 68 non resectable metastatic 68 antiangiogenesis therapies 68 CIMZIA TM certolizumab pegol 68 itraconazole Sporanox 68 vascular occlusive diseases 68 Quinamed 68 aflibercept VEGF Trap 68 Copegus ribavirin 68 non peptidic protease 68 Vicriviroc 68 abacavir lamivudine 68 Initiate Clinical Trial 68 SinuNase TM 68 Potassium Chloride Sodium Ascorbate 68 Pharmacokinetics PK 68 Orally Active 67 ramipril Altace 67 Initiates Phase 2b 67 deforolimus 67 HCl PEPCID ® famotidine 67 Pertuzumab 67 sunitinib Sutent 67 Files IND 67 included exfoliative dermatitis 67 imatinib Gleevec ® 67 YONDELIS 67 Perifosine KRX 67 Vitrasert R 67 AEG# 67 ALVESCO ® 67 Initiated Phase 67 Peginterferon Alfa 2a 67 fosbretabulin 67 Angiotensin Converting Enzyme 67 agonistic human 67 First Patient Dosed 67 investigational HCV polymerase 67 limiting toxicity DLT 67 TAXUS Element Paclitaxel Eluting 67 investigational humanized monoclonal antibody 67 Orally administered 67 aldehyde dehydrogenase ALDH2 deficiency 67 CYP#A# isoenzyme 67 Thiarabine 67 radiation sensitizer 67 Wafer polifeprosan 67 carcinoma mCRC 67 PKC# 67 Achieves Primary Endpoint 67 PROCTOCORT ® Suppository Hydrocortisone 67 substantially excreted 67 R MSCRAMM 67 Carboplatin Paclitaxel 67 Pegloticase 67 CYP#A# substrate 67 lenalidomide Revlimid 67 Tekamlo 67 IIIa inhibitor 67 Vascular Disrupting Agent 67 TRANSDUR ™ 67 Myocet 67 evaluating Xcytrin 67 Oral Calcitonin 67 DOXIL R 67 Kuvan sapropterin dihydrochloride 67 xanthine oxidase inhibitor 67 PROSTASCINT R 67 chemotherapy cisplatin 67 Safinamide 67 OMP #M# 67 Archexin 67 VELCADE melphalan 67 entinostat 67 R bisoprolol Euthyrox 67 Prolongs Survival 67 COLAZAL R 67 R ferumoxytol Injection 67 receiving chemoradiation therapy 67 neutropenia dehydration dyspnea 67 refractory cutaneous T 67 LHRH receptor positive 67 phenylketonuria PKU developed 67 refractory metastatic 67 nilotinib Tasigna 67 adriamycin 67 Tipranavir 67 oral proteasome inhibitor 67 plus COPEGUS 67 relapsed refractory multiple myeloma 67 cyclophosphamide chemotherapy 67 cell lymphoma CTCL 67 neuropathy sparing 67 anthracycline taxane 67 J Antimicrob Chemother 67 cortisol synthesis 67 Selzentry Celsentri 67 cediranib 67 Telik Announces 67 combining voreloxin 67 AKT inhibitor 67 primidone 67 hyaluronidase enzyme 67 serologically active systemic lupus 67 basal bolus regimen 67 INTEGRILIN ® 67 substrates inhibitors 67 lamotrigine Lamictal 67 Presents Positive 67 cytidine nucleoside analog 67 Genasense ® oblimersen 67 arsenic trioxide injection 67 mGluR2 positive 67 unresectable tumors 67 EGFr expressing metastatic colorectal 67 estramustine 67 Lenocta TM sodium stibogluconate 67 Namenda Memantine HCl 67 potent CYP#A# inhibitors 67 PEGylated anti 67 Ixempra 67 #HT# 67 Submits Biologics License Application 67 peginterferon alfa 2a Pegasys 67 5 HT2A inverse 67 By JAMAAL ABDUL 67 Newly Diagnosed Multiple Myeloma 67 rosuvastatin #mg 67 J Am Coll 67 pyrexia mucositis sepsis febrile 67 Dose Escalation 67 % hydrocortisone acetate 67 histone deacetylase HDAC inhibitor 67 non porcine pancreatic 67 investigational pharmacologically unique 67 tumor xenograft models 67 Amgen Neulasta ® 67 EOquin TM phase 67 BRIM2 67 MCSP respectively 67 IMA# 67 selective androgen receptor modulator 67 Severe Sepsis 67 Immunotherapeutic 67 GEM OS2 67 sulfonylurea metformin 67 Lenalidomide 67 TRAIL R1 67 R metformin Concor 67 IAP inhibitors 67 TRACON Pharmaceuticals 67 fluoropyrimidine 67 bazedoxifene conjugated estrogens 67 Hydrochlorothiazide Tablets 67 DIFICID ™ 67 PORxin TM platforms 67 FOLFOX chemotherapy 67 Granted Orphan Drug 67 Sanofi Pasteur Fluzone 67 Trastuzumab DM1 67 irinotecan containing 67 delivers fluocinolone acetonide FA 67 alpha interferons 67 Mylan Receives Approval 67 developing ACAPODENE 67 events thrombocytopenia neutropenia 67 Epratuzumab 67 introduced NEUGENE 67 peripherally acting 67 Coadministration 67 Irinotecan 67 sulfonylhydrazine class 67 5 FU capecitabine 67 folinic acid FA 67 Phase Ib II 67 Adenoscan R 67 pancreatic prostate 67 ficlatuzumab 67 pipeline ImmunoGen collaborators 67 OMP #R# 67 Adjuvant Treatment 67 ospemifene 67 delivery polymer matrix 67 Pegasys plus Copegus 67 Pooled Analysis 67 selective inverse agonist 67 colesevelam HCl 67 corticotropin injection 67 SIMCOR 67 Aliskiren 67 vinorelbine tartrate 67 please visit http:/www.vandapharma.com 67 alpha folate receptor 67 ADVANCE ILLUMINATE 67 PANVAC VF 67 targeted radiotherapeutic 67 Improved Progression 67 novel tubulin binding 67 Heterozygous Familial Hypercholesterolemia 67 proteasome inhibitor 67 EMD # 67 HuMax EGFr 67 Amlodipine Besylate 67 ziprasidone Geodon 67 Lixivaptan 67 mGluR5 negative 67 Statin medicines sold 67 TURNING INSIGHTS INTO HOPE 67 include Healive TM 67 oral ferric iron 67 ritonavir boosted atazanavir 67 GW# [003] 67 malignant mesothelioma Alfacell 67 Reports Preclinical Data 67 Intervention Effectiveness 67 clinical trials Archexin ® 67 ENABLE Phase 2 67 budesonide pMDI 67 administered concomitantly 67 CIMZIA R 67 YOUR LOCAL ANIMAL SHELTER 67 Novartis Trileptal 67 active AKT inhibitor 67 Anti Tumor 67 Chemophase 67 Submits NDA 67 XP# XP# 67 PSMA ADC 67 Randomized Double Blind 67 phase IIb clinical 67 ixabepilone 67 Anti Tumor Activity 67 peginterferon alfa 2b 67 intranasal formulation 67 TOCOSOL Camptothecin 67 tranquilizers diazepam 67 R#/MEM # 67 somatostatin analog 67 Phase IIb Clinical Trial 67 particularly SANCTURA XR 67 Obatoclax 67 Drug Candidate 67 LEVAQUIN ® 67 CTA# Injection 67 Selective Electrochemical Tumor Ablation 67 TKB# 67 Phase #b/#a trial 67 Warner Chilcott Actonel 67 panitumumab Vectibix R 67 Second Pivotal Phase 67 Evoltra ® 67 Eraxis 67 trastuzumab DM1 T DM1 67 next generation URAT1 67 Soft Tissue Sarcoma 67 aspirin heparin 67 hydrocortisone prescription 66 Eyvind Brynildsen Mitsubishi Lancer 66 zileuton injection 66 5mg #mg 66 Staphylococcus aureus Immune Globulin 66 Intravitreal 66 D aspartate NMDA receptor 66 Chronic Hepatitis C 66 SUTENT ® 66 II Clinical Trial 66 Platinol ® 66 prescribed estrogen progestin 66 MSCRAMM ® 66 PLX STROKE targeting 66 vidofludimus 66 Intravitreal injections 66 investigational immunotherapy 66 gemcitabine cisplatin 66 DO YOU NEED TO 66 Clolar ® 66 adalimumab Humira 66 CYT# vascular disrupting 66 chemotherapy molecularly targeted 66 M# rationally 66 Entereg TM 66 bucindolol hydrochloride 66 non constipating irritable 66 investigational protease inhibitor 66 THR beta agonist 66 DOXIL 66 Perforomist TM formoterol fumarate 66 PEGylated docetaxel 66 CD#.# DOES NOT ENDORSE 66 estrogen receptor beta agonist 66 cromolyn sodium 66 Pegylated Liposomal Doxorubicin 66 neovascular diseases 66 See CLINICAL PHARMACOLOGY 66 triple VEGF receptor 66 candesartan cilexetil 66 transthyretin mediated amyloidosis ATTR 66 8mg/kg 66 SYNERGY Stent 66 Philadelphia Chromosome Positive 66 pharmacodynamic properties 66 Cardium Therapeutics TM 66 PF # [002] 66 develop HBV reactivation 66 Nilotinib 66 peginterferon alpha 2a 66 IMC A# 66 Pivotal Phase III 66 hyperplasia BPH 66 Inhalation Aerosol 66 Phase 2a Trial 66 Warfarin Coumadin 66 Provectus Pharmaceuticals specializes 66 topically applied SEPA 66 BIOTECHNOLOGY INDUSTRY 66 sargramostim 66 Alpha interferons including 66 induce orthostatic hypotension 66 TLR7 agonist 66 mg RDEA# 66 angiotensin converting enzyme inhibitor 66 molecular imaging radiopharmaceutical 66 Phase Ib clinical 66 WHILE THE COMPANY 66 venlafaxine Effexor 66 known sulfonamide allergy 66 Adjunctive Therapy 66 IG HCR ;) CO 66 tyrosine kinase inhibitor TKI 66 Initiate Phase III 66 Plecanatide 66 SPL# Gel vaginal microbicide 66 Teva Provides Update 66 Phase Ib IIa 66 Navelbine ® 66 docetaxel Taxotere 66 First Patient Enrolled 66 investigational monoclonal antibody 66 relapsed myeloma 66 R rilonacept Injection 66 NVA# 66 reduce serum phosphate 66 aripiprazole Abilify 66 ARIKACE ™ 66 aplindore 66 PEGylated Fab fragment 66 alpha 2a 66 COPEGUS 66 NASH Huntington 66 Alkeran 66 BARACLUDE R 66 huN# DM1 66 severe hypercholesterolemia 66 Diovan Exforge Tekturna Zelnorm 66 Prescription acetaminophen 66 Enrolls First 66 erythematosus SLE 66 Array BioPharma Reports 66 Pivotal Study 66 PATENT FOR 66 Triapine R 66 novel immunomodulatory 66 either acutely decompensated 66 methylergonovine 66 cladribine Cladribine Tablets 66 metabolic alkalosis 66 oral renin inhibitor 66 SAR# [004] 66 Letairis ambrisentan 66 Combo Stent 66 Fondaparinux 66 Acetate Rectal Suppositories 66 Interferon alfa 2b 66 recurrent glioblastoma multiforme 66 stage IIIb IV 66 generation PNP inhibitor 66 vincristine doxorubicin 66 Tyrima 66 #mg/#mg 66 includes TOLAMBA TM 66 Biogen Genentech 66 Suppository Hydrocortisone Acetate Rectal 66 Proc Am Soc 66 midstage clinical 66 Taxotere chemotherapy 66 antiretroviral naïve 66 K ras mutations 66 aMCI precursor 66 polyglutamate 66 PRT# 66 Ostabolin C TM 66 unresectable Stage III 66 Gel repository corticotropin injection 66 markets HP Acthar 66 candidate CRLX# 66 VERTEX PHARMACEUTICALS 66 hereditary emphysema 66 BENICAR HCT 66 thiazolidinedione TZD 66 class anticancer quinolone 66 pharmacokinetic equivalence 66 Kuvan R 66 Relapsed Multiple Myeloma 66 signal detection CTSD 66 Multiple Myeloma MM 66 amlodipine beta blockers 66 Vidaza azacitidine 66 Temodar ® 66 Recurrent Glioblastoma 66 Altera Nebulizer System 66 assessing T DM1 66 GREEN MILL 66 Gemzar gemcitabine 66 cell carcinoma RCC 66 subtype selective NMDA receptor 66 Synta Announces 66 Idec Roche Takeda 66 sitagliptin Januvia 66 PHX# 66 TRIOLEX ™ 66 testing huN# DM1 66 REVIVE Diabetes 66 chemotherapy gemcitabine 66 oral dihydropyrimidine dehydrogenase DPD 66 pomalidomide 66 highly selective inhibitor 66 pathophysiological effects 66 Silodosin 66 High Dose quadruples 66 Known hypersensitivity 66 interferon alfa 2b 66 EPIVIR 66 antimetastatic activity 66 Placebo Controlled 66 Paroxysmal Nocturnal Hemoglobinuria PNH 66 Phase III Trial 66 PDE4 inhibitor 66 initiated Phase Ib 66 salmeterol inhalation powder 66 cyclophosphamide FC 66 Improves Survival 66 papillary renal cell carcinoma 66 ELADUR ™ 66 chemosensitizer 66 folate analogue metabolic 66 5 HT6 receptor 66 lipid lowering agents 66 Famvir R 66 oral salmon calcitonin 66 Anti Bacterial Envelope 66 Eluting Stent 66 HER2 positive metastatic breast 66 cutaneous T 66 Pegylated Interferon 66 AVOREN 66 include VALSTAR TM 66 SIX BSLN 66 VANTAS ® 66 mertansine 66 TRX1 66 Aptivus ® 66 metastatic castrate resistant 66 PRESENTED AT 66 Long acting beta2 66 Receives Approvable Letter 66 var arrContent = 66 DAVANAT 66 Cloretazine ® 66 familial amyloidotic polyneuropathy FAP 66 Preclinical Data 66 By JESSE SMITHEY 66 unfractionated heparin UFH 66 CHOP chemotherapy 66 Actonel risedronate 66 novel histone deacetylase 66 novel nucleoside analog 66 post herpetic neuralgia PHN 66 WHO TOOK 66 METOZOLV TM ODT metoclopramide 66 methotrexate MTX 66 stent DES